• Profile
Close

Comparison of sofosbuvir plus ribavirin treatment with pegylated interferon plus ribavirin treatment for chronic hepatitis C genotype 2

Digestive Diseases Oct 28, 2017

Seo K, et al. - This study aimed to compare the efficacy of sofosbuvir plus ribavirin (RBV) treatment with pegylated interferon (peg-IFN) plus RBV treatment for chronic hepatitis C genotype 2. Compared to peg-IFN plus RBV, the treatment with sofosbuvir plus RBV resulted in not only a higher sustained virological response (SVR) but also improved the liver function and the degree of fibrosis.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay